Skip to main content
. 2016 Sep 15;7(42):68442–68448. doi: 10.18632/oncotarget.12035

Figure 2. Comparison of overall survival (OS).

Figure 2

Kaplan–Meier survival curves for OS analyses between first- and second-line TKI therapies. TKI, tyrosine kinase inhibitor.